Sales and adjusted EBITDA margin for Q1 well up on corresponding quarter of previous year Solid incoming orders lay ...

A majority of marijuana consumers say their use of cannabis has had a “positive” impact on their careers, according to a new ...

Strong fundamentals, successful line-up and resilience set stage for H2 margin growth ...

According to a Moneycontrol poll of seven brokerage firms, the Wagon-R maker is anticipated to record a 2.9 percent ...

New mothers say they had to undergo devastating investigations after hospitals reported their false positive drug tests to child welfare agencies shortly after they gave birth. “It was torture; it was ...

New research reveals how structural brain connectivity shapes psychopathic traits and externalizing behaviors.

Roche’s Itovebi gets European approval to treat people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation: Basel Thursday, July 24, 2025, 09:00 Hrs [ ...

A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for ...

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...

On July 16, 2025, the Sun transits into Cancer, influencing emotions, health, and relationships. Discover zodiac-wise predictions.

Saturn turns retrograde in Pisces. Discover how this 138-day phase will influence each zodiac sign with karmic shifts, delays, and spiritual growth opportunities.

Lumine Group benefits from its smaller size to maintain a high acquisition rate. Click here to find out why LMN:CA is a Hold.